Showing 8351-8360 of 20416 results for "".
From HCM to ATTR-CM: Rethinking Unexplained Hypertrophy
https://reachmd.com/programs/Audioabstracts/hcm-attr-cm-unexplained-hypertrophy/49052/In older patients with unexplained hypertrophy, the default diagnosis of hypertrophic cardiomyopathy (HCM) may overlook a common culprit: transthyretin amyloid cardiomyopathy (ATTR-CM). In this AudioAbstract, Dr. Hallie Blevins explores the TTRACK study, which uncovered a striking prevalence of ATTRRedefining Non-Small Cell Lung Cancer Care: Updates in Targeted and Perioperative Therapy
https://reachmd.com/programs/deep-breaths-updates-chest/nsclc-targeted-perioperative-therapy/35983/The 2025 European Society for Medical Oncology Congress and World Conference on Lung Cancer revealed significant updates in non-small cell lung cancer care. Learn more as Drs. Gerard Silvestri, Mariam Alexander, and Jessica Donington review new data on EGFR- and ROS1-targeted therapies, perioperativEarly Adulthood Weight Gain Linked to Breast Tissue Complexity Changes
https://reachmd.com/programs/project-oncology/early-adulthood-weight-breast-tissue-complexity/48767/Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
https://reachmd.com/programs/neurofrontiers/understanding-antibody-mediated-demyelinating-diseases-key-differences-from-ms/32821/Antibody-mediated demyelinating diseases, such as neuromyelitis optica spectrum disorder and MOG antibody disease, differ fundamentally from multiple sclerosis (MS) due to their association with specific antibodies. Dr. Michael Levy explains how these conditions progress, how relapses can driMaximizing Outcomes: Strategic Approaches in Metastatic CRC Treatment
https://reachmd.com/programs/cme/maximizing-outcomes-strategic-approaches-in-metastatic-crc-treatment/36513/Explore expert recommendations for optimizing clinical outcomes with targeted treatment combinations in BRAF-mutant mCRC.Nicotinamide for COVID-19 Recovery: Restoring Metabolic Balance
https://reachmd.com/programs/clinicians-roundtable/nicotinamide-for-covid-19-recovery-restoring-metabolic-balance/36410/Transforming Clinician Wellness: EEG Headphones Helping with Burnout
https://reachmd.com/programs/neurofrontiers/transforming-clinician-wellness-eeg-headphones-helping-with-burnout/32872/Neuro-responsive EEG headphones are helping healthcare professionals combat burnout by promoting calm, focus, and resilience. Backed by neuroscience and real-time brain monitoring, this personalized technology blends music and neurofeedback to optimize mental states and reduce stress. Hear from VitaOptimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
https://reachmd.com/programs/frontlines-schizophrenia/optimizing-schizophrenia-care-strategies-for-managing-side-effects-and-treatment-resistance/30035/Learn about strategies for managing common therapeutic challenges in schizophrenia.Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
https://reachmd.com/programs/neurofrontiers/reducing-cortical-lesions-in-ms-with-ocrelizumab-results-from-the-oratori-study/26763/Does the B-cell therapy ocrelizumab have the potential to slow down cortical lesions or even stop them in multiple sclerosis (MS)? That’s the exact question the ORATORI study sought to answer, and based on the findings, not only did ocrelizumab reduce new and enlarging cortical lesions by 75 percentMutational Testing in mCRC: Methods and Data Driving Treatment Selection
https://reachmd.com/programs/cme/MutationalTestinginmCRcMethodsandDataDrivingTreatmentSelection/32942/Explore expert recommendations for optimizing clinical outcomes with targeted treatment combinations in BRAF-mutant mCRC.